EMD is heading to phase 3 soon. once a bio tech company start phase 3, the market will pay huge attention on it. EMD is directly compare with the only FDA approved drug which make $700m sales a year.
EMD has over 100 MDMA analogues for the psychedelic drugs. the US and Canadian companies with much less MDMA analogues but their mc valuation already lot higher than EMD market cap. IMO, EMD is significantly undervalued.
the coming weeks/months will be very exciting. can't wait to see more news.
EMD Price at posting:
30.0¢ Sentiment: Buy Disclosure: Held
